STO · SIMRIS-B.ST
Simris Alg AB (publ)
SEK 0.13+SEK 0.00 (+2.88%)
Simris Alg AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 35.9% below the high.
Loading market information…
STO · KONT.ST · SEK
Stock price, earnings
Quote as of Oct 21, 2026, 10:21 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SEK. Historical prices are not a forecast.
Kontigo Care AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 49.38% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Kontigo Care AB (publ)’s next earnings report is currently expected on Nov 5, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Kontigo Care AB (publ)’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Gambling, a digital application for tackling gambling addiction. Established in 2013, the firm maintains its primary operations in Uppsala, Sweden.
Latest available per-share figures in SEK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2024 | Nov 11, 2024 | SEK 0.02 | SEK 7.61M-30.82% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SEK 0.13+SEK 0.00 (+2.88%)
Simris Alg AB (publ)’s quoted price sits in the upper half of its reported 52-week range, 35.9% below the high.
SEK 16.70-SEK 0.20 (-1.18%)
Scandinavian Real Heart AB (Publ)’s quoted price sits in the lower half of its reported 52-week range, 29.54% below the high.
SEK 3.19-SEK 0.18 (-5.34%)
AcouSort AB’s quoted price sits in the lower half of its reported 52-week range, 38.18% below the high.
SEK 1.58+SEK 0.02 (+1.28%)
Newbury Pharmaceuticals AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 79.95% below the high.
SEK 3.19+SEK 0.06 (+1.92%)
OncoZenge AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 68.97% below the high.
SEK 0.56SEK 0.00 (0.0%)
ScandiDos AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 57.58% below the high.
SEK 0.04+SEK 0.00 (+0.5%)
Spago Nanomedical AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 80.95% below the high.
SEK 0.02+SEK 0.00 (+2.61%)
SpectraCure AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 93.5% below the high.
